Latest posts by Michael Hamilton (see all)
- Big Labor Bullies First Amendment with Scientology Playbook - August 3, 2017
- Blame The Free Market, Comrade - May 17, 2017
- Dentists Know Best, So Let Them Choose - April 26, 2017
The Tomorrow’s Cures Today Foundation (TCTF) says FDA regulations deprive terminally ill patients and their family members of hope.
In a video posted February 6, TCTF tells the story of former U.S. Navy pilot Matt Bellina’s battle with amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease, which causes nerve cells in the brain and spinal cord to degenerate.
ALS is a terminal diagnosis. In 2015, Bellina and 800,000 supporters unsuccessfully petitioned FDA to approve experimental use of a drug reported to yield positive results for ALS patients, the video states.
TCTF’s website (TomorrowsCuresToday.com) calls for replacing FDA’s cumbersome regulations, which includes a long clinical trials process, with a market-based policy known as Free to Choose Medicine (FTCM).
FTCM “addresses the key constraint to improving the drugs-to-patients system: the lack of consumer choice and competition due to the FDA’s monopoly over access to new drugs,” the site states.
More information: FreeToChooseMedicine.com